Robuvit
Also known as: Robuvit, French oak wood extract, ellagitannin-rich extract, Quercus robur extract
Overview
Robuvit is a standardized, water-extracted polyphenol extract derived from the wood of the French oak tree (Quercus robur). It is particularly rich in a class of ellagitannins known as roburins, which are also naturally present in oak wood used for aging beverages. This supplement is primarily utilized to enhance energy metabolism, alleviate fatigue, support recovery from mild health impairments, and promote liver and cardiovascular well-being. Its key characteristic lies in its ability to increase circulating urolithins (A, B, C), which are beneficial microbial metabolites of ellagitannins linked to improved mitochondrial health. Research on Robuvit is moderately developed, with over 20 clinical trials involving more than 1100 subjects, including randomized controlled trials (RCTs). While independent clinical studies show promising results, comprehensive systematic reviews or meta-analyses specifically on Robuvit are currently limited.
Benefits
Robuvit offers several evidence-based benefits, primarily centered around energy and recovery. It significantly reduces chronic fatigue symptoms and boosts energy levels, with one RCT reporting up to a 48% increase in energy in fatigued adults. For athletes, supplementation has been shown to enhance physical performance, including improvements in triathlon performance after 12 weeks. Robuvit also supports liver health by improving recovery from mild hepatic injury and normalizing liver function markers such as bilirubin and AST, while increasing albumin. Secondary benefits include improved sleep quality, with a 33% increase in sleep duration and a 44% reduction in unrefreshing sleep, and mood improvements, including a 58% reduction in depressive feelings and 49% fewer mood swings. It has also shown promise in alleviating fatigue in patients with mild heart failure (58% reduction). Preliminary evidence suggests potential improvements in erectile function and vigor in elderly men. These benefits are particularly relevant for chronically fatigued individuals, patients with mild liver or heart insufficiency, athletes, and the elderly. Effect sizes are statistically significant, with fatigue reduction ranging from 12% to 58% and sleep/mood improvements up to 33-58%. Benefits are typically observed within 4 weeks to 6 months of daily 300 mg supplementation.
How it works
Robuvit's mechanism of action primarily revolves around its ellagitannins being metabolized by gut microbiota into bioactive urolithins, particularly urolithin A, B, and C. These urolithins are crucial for promoting mitophagy, a cellular process that removes dysfunctional mitochondria and facilitates the renewal of healthy ones, thereby enhancing cellular energy production. Additionally, Robuvit metabolites appear to stimulate ribosomal biogenesis in various cell types, including endothelial, neuronal, and keratinocyte cells, which may accelerate protein synthesis and contribute to improved physical endurance. The extract also possesses antioxidant properties and supports liver detoxification pathways, contributing to overall organ function improvement. Urolithins are primarily found in serum, indicating their systemic bioavailability after ingestion.
Side effects
Robuvit is generally considered well-tolerated, with no serious adverse events reported across clinical trials involving over 1100 subjects. Mild gastrointestinal discomfort may occur, but it is rare and not reported at rates exceeding 5%. No significant drug interactions or contraindications have been documented in the scientific literature to date. Clinical studies have shown that special populations, such as individuals with mild heart failure or liver insufficiency, have tolerated the supplement well. While long-term safety data beyond 6 months are limited, current evidence does not indicate any safety concerns or adverse signals for continued use within the recommended dosage.
Dosage
The minimum effective and optimal dosage for Robuvit is consistently 300 mg per day of the standardized extract. This dose has been used across various clinical studies. It can typically be administered as a single daily dose or in divided doses. An explicit maximum safe dose has not been defined, but clinical trials have demonstrated safety at 300 mg/day without any reported concerns. For observable benefits, daily supplementation should be maintained for at least 4 weeks, with longer durations (up to 6 months) yielding sustained and maximal improvements. Robuvit is available in oral forms such as capsules or tablets. Its absorption and efficacy are dependent on individual gut microbiota metabolism of ellagitannins into urolithins, meaning individual responses may vary based on differences in urolithin production capacity.
FAQs
Is Robuvit safe for long-term use?
Clinical data supports safety for up to 6 months of use. While longer-term safety data are limited, no adverse signals have been reported, suggesting it is likely safe for extended periods.
How quickly will I see results?
Some benefits, such as fatigue reduction and mood improvement, may become noticeable within 4 weeks. However, maximal effects often require consistent supplementation for 3 to 6 months.
Does everyone respond the same?
Individual responses to Robuvit can vary. This is primarily due to differences in gut microbiota composition, which affects the production of beneficial urolithins from the supplement.
Can Robuvit replace other fatigue treatments?
Robuvit may complement existing medical treatments for fatigue but should not be considered a replacement. Always consult a healthcare provider for chronic conditions or before making changes to your treatment plan.
Research Sources
- https://www.liebertpub.com/doi/pdf/10.1089/jmf.2020.0165 – This source describes an RCT (Weichmann et al., 2020) involving 80 chronically fatigued adults, showing a 48% increase in energy and significant fatigue reduction with Robuvit. It also covers an RCT with 44 recreational athletes demonstrating improved triathlon performance and liver markers, and another RCT with 61 patients with moderate hepatic injury showing accelerated liver function recovery. The study highlights Robuvit's efficacy in improving energy, performance, and liver health.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8573807/ – This source, likely part of the Weichmann et al., 2020 research, details the significant reduction in chronic fatigue symptoms and improvement in energy levels observed in an RCT with 80 participants. It reinforces the primary benefit of Robuvit in combating fatigue and enhancing overall energy, providing specific percentage improvements.
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00074/full – This pharmacokinetic study (Frontiers in Pharmacology, 2020) confirms the presence of urolithins in the serum after Robuvit ingestion, supporting its bioavailability. It provides crucial mechanistic insight into how Robuvit's active compounds are absorbed and circulate in the body, underpinning its biological effects.
- https://nutraceuticalbusinessreview.com/how-robuvit-can-help-with-mood-swings-restless-sleep-stress-and-fatigue--200929 – This article discusses Robuvit's benefits beyond just fatigue, including improvements in sleep quality (33% more sleep, 44% reduction in unrefreshing sleep) and mood (58% reduction in depressive feelings, 49% fewer mood swings). It also mentions alleviation of fatigue in mild heart failure patients, broadening the scope of Robuvit's potential applications.
- https://pubmed.ncbi.nlm.nih.gov/33512270/ – This source, likely a review or ex vivo study (Weichmann et al., 2020), delves into the mechanistic aspects of Robuvit. It demonstrates increased urolithin production, enhancement of mitophagy (mitochondrial renewal), and ribosomal biogenesis, providing a strong biological plausibility for Robuvit's effects on energy and cellular function. It also confirms the safety profile with no serious adverse events in over 1100 subjects.
